Literature DB >> 17111160

Renal caveolin-1 expression in children with unilateral ureteropelvic junction obstruction.

Patricia G Vallés1, Walter Manucha, Liliana Carrizo, José Vega Perugorria, Alicia Seltzer, Celeste Ruete.   

Abstract

Caveolae are plasma membrane invaginations that contain a variety of signal transduction molecules and receptors for growth factors and cytokines. This study was performed to examine the in vivo expression and localization of caveolin-1 in kidneys from 19 children who underwent surgery release of ureteropelvic junction obstruction (UPJO) in relation to renal function and degree of tubulointerstitial fibrosis. Renal biopsies were carried out at the time of surgery for obstruction release. Kidney tissue from children of similar age removed because of carcinoma was used as control. Expression of caveolin-1 at the protein level in renal tissue and urine was demonstrated in patients with technetium 99 m labeled diethylene triamine pentaacetate ((99)Tc DTPA) renal scan 28.8+/-2% and increased tubular interstitial fibrosis in seven patients at the time of obstruction release. Colocalization staining of AT(1) angiotensin II receptor with caveolin-1 in basolateral membrane of epithelial tubule cells, enhanced AT(1) messenger ribonucleic acid (mRNA) and decreased endothelial nitric oxide synthase (eNOS), were shown in these patients. In contrast, absence of association of caveolin-1 with AT(1) receptor expression in proximal and collecting tubule membranes with AT(1) receptor mRNA and eNOS mRNA expression near control were demonstrated in 12 patients, with (99)Tc DTPA renal scan 39.7+2.1% and no evidence of tubulointerstitial fibrosis. From our results, the role of caveolin-1 as a factor contributing to the severity of the tubulointerstitial process resulting from obstructive nephropathy could be suggested.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17111160     DOI: 10.1007/s00467-006-0290-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  43 in total

Review 1.  Cell apoptosis and proliferation in obstructive uropathy.

Authors:  L D Truong; D Sheikh-Hamad; S Chakraborty; W N Suki
Journal:  Semin Nephrol       Date:  1998-11       Impact factor: 5.299

2.  Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study.

Authors:  B A Warady; D Hébert; E K Sullivan; S R Alexander; A Tejani
Journal:  Pediatr Nephrol       Date:  1997-02       Impact factor: 3.714

Review 3.  Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.

Authors:  T Okamoto; A Schlegel; P E Scherer; M P Lisanti
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

4.  Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction.

Authors:  K A Hruska; G Guo; M Wozniak; D Martin; S Miller; H Liapis; K Loveday; S Klahr; T K Sampath; J Morrissey
Journal:  Am J Physiol Renal Physiol       Date:  2000-07

5.  Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane.

Authors:  C Mineo; G L James; E J Smart; R G Anderson
Journal:  J Biol Chem       Date:  1996-05-17       Impact factor: 5.157

Review 6.  Angiotensin II and gene expression in the kidney.

Authors:  S Klahr; J Morrissey
Journal:  Am J Kidney Dis       Date:  1998-01       Impact factor: 8.860

7.  Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia.

Authors:  S E Thomas; S Anderson; K L Gordon; T T Oyama; S J Shankland; R J Johnson
Journal:  J Am Soc Nephrol       Date:  1998-02       Impact factor: 10.121

8.  Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.

Authors:  You-Yang Zhao; Yang Liu; Radu-Virgil Stan; Lian Fan; Yusu Gu; Nancy Dalton; Po-Hsien Chu; Kirk Peterson; John Ross; Kenneth R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

9.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

10.  Peritubular capillary regression during the progression of experimental obstructive nephropathy.

Authors:  Ryuji Ohashi; Akira Shimizu; Yukinari Masuda; Hiroshi Kitamura; Masamichi Ishizaki; Yuichi Sugisaki; Nobuaki Yamanaka
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

View more
  5 in total

1.  Lipid rafts are required for effective renal D1 dopamine receptor function.

Authors:  Andrew C Tiu; Jian Yang; Laureano D Asico; Prasad Konkalmatt; Xiaoxu Zheng; Santiago Cuevas; Xiaoyan Wang; Hewang Lee; Momina Mazhar; Robin A Felder; Pedro A Jose; Van Anthony M Villar
Journal:  FASEB J       Date:  2020-04-07       Impact factor: 5.191

Review 2.  Congenital ureteropelvic junction obstruction: human disease and animal models.

Authors:  Julie Klein; Julien Gonzalez; Mathieu Miravete; Cécile Caubet; Rana Chaaya; Stéphane Decramer; Flavio Bandin; Jean-Loup Bascands; Bénédicte Buffin-Meyer; Joost P Schanstra
Journal:  Int J Exp Pathol       Date:  2010-07-30       Impact factor: 1.925

Review 3.  Membrane rafts and caveolae in cardiovascular signaling.

Authors:  Paul A Insel; Hemal H Patel
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

4.  Injury induced expression of caveolar proteins in human kidney tubules - role of megakaryoblastic leukemia 1.

Authors:  Krzysztof M Krawczyk; Jennifer Hansson; Helén Nilsson; Katarzyna K Krawczyk; Karl Swärd; Martin E Johansson
Journal:  BMC Nephrol       Date:  2017-10-24       Impact factor: 2.388

Review 5.  The molecular biology of pelvi-ureteric junction obstruction.

Authors:  Laura Jackson; Mark Woodward; Richard J Coward
Journal:  Pediatr Nephrol       Date:  2017-03-13       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.